!"#$%&'()*+,(*,-./++(++(,
0/12/1',3&4/5,!&'&#/1,6&'7/,(*,8&/19,:;#/1<,=++&,,
,
,>&,7.$+(,#?1),'"#$%&'()*,7&.,1)(,9(''(,()%($)*(,(@7/+(,(),
-")".&<,A,<&,9/$+,<&,'B.(,(*,<?()9&)*,A,)&C*.(,A,%(,'"#$%&'()*D,
E)F$./),GH,#(+,'&<9/.'&*$/)+,A,<&,)&$++&)%(,+/)*,<$"+,&1@,(99(*+,
*/@$I1(+,'"#$%&'()*(1+(+,J(99(*+,*".&*/-B)(+KD,L/1+,<(+,
'"#$%&'()*+,&**($-)()*,<(,9M*1+,%&.,*.&F(.+&)*,<&,;&..$B.(,
7<&%()*&$.(,A,<?(@%(7*$/),#(+,-./++(+,'/<"%1<(+,%/''(,<?$)+1<$)(D,
N<&++$I1('()*,(*,+%2"'&*$I1('()*5,<(+,7.$)%$7&1@,.$+I1(+,%/))1+,#$99B.()*,+(</),<(,+*&#(,
#(,#"F(</77('()*,#(,<?()9&)*,O,,
(';.P/-()B+(,/1,7".$/#(,(';.P/))&$.(,&1,7.('$(.,*.$'(+*.(,#(,<&,-./++(++(,O,
&F/.*('()*+,(*,'&<9/.'&*$/)+,%/)-")$*&<(+Q,
'&*1.&*$/),#(+,/.-&)(+,/1,7".$/#(,9M*&<(,&1@,#(1@$B'(,(*,*./$+$B'(,
*.$'(+*.(+,O,*./1;<(+,#1,#"F(</77('()*,(*,#1,9/)%*$/))('()*,#(+,/.-&)(+Q,,
7".$/#(,7.B+,#(,<&,)&$++&)%(,(*,<?&%%/1%2('()*,O,7(.*1.;&*$/)+,#(,<?&%%/1%2('()*,(*,
$'7."-)&*$/),#1,)/1F(&1R)"D,
>(,%"<B;.(,'&-&+$)(,S.(+%.$.(,&,71;<$",TU,7.$)%$7(+,7/1.,"F$*(.,<(+,(99(*+,$)#"+$.&;<(+,%2(V,
<?()9&)*,A,)&C*.(,(@7/+",$),1*(./,A,#(+,'"#$%&'()*+,
TD S.1#()%(,%2(V,*/1*(,9(''(,()%($)*(,/1,7(1*RW*.(,()%($)*(,/1,I1$,7/1..&,<(,#(F()$.,
;$()*X*D,
YD N(.*&$)+,'"#$%&'()*+,+/)*,)/*/$.('()*,*".&*/-B)(+,/1,9/(*/*/@$I1(+,
ZD [.&)#(+,$)%(.*$*1#(+,(*,'"%/))&$++&)%(+,7/1.,<&,7<17&.*,#(+,'"#$%&'()*+,
\D EF$*(.,<(+,*.&$*('()*+,#/)*,<?(99$%&%$*",(+*,*./7,$)%(.*&$)(,
GD L()$.,%/'7*(,A,<&,9/$+,#(,<&,'B.(,(*,#(,<?()9&)*,7/1.,"F&<1(.,<&,;&<&)%(,;")"9$%(,
.$+I1(D,
]D S."%&1*$/)+,'&@$'&<(+,&1,7.('$(.,*.$'(+*.(,O,'"#$%&'()*,#(,."9".()%(5,A,#/+(,(*,
#1."(,'$)$'&<(+,(99$%&%(+D,
^D E),9$),#(,-./++(++(,O,+(,9$(.,&1,7./9$<,#?(99(*+,%/))1+,7&.,&$<<(1.+,
_D >?$-)/.&)%(,#(+,(99(*+,A,</)-,*(.'(,+1.,<(,#"F(</77('()*,#(,<?()9&)*,$)%$*(,A,<&,
7.1#()%(,
`D =)9/.'(.,<(+,7&*$()*(+,#(+,#&)-(.+,#(+,'"#$%&'()*+,7()#&)*,<&,-./++(++(,
TUD a.-&)$+(.,<&,+1.F($<<&)%(,(*,<&,7.$+(,(),%2&.-(,#(+,(99(*+,$)#"+$.&;<(+,7."F$+$;<(+,%2(V,
<(+,()9&)*+D,
>(+,*&;<(&1@,T5,Y,(*,Z,."+1'()*,<(+,#$99".()*(+,+$*1&*$/)+,/b,<(+,'"#$%&'()*+,+/)*,
*".&*/-B)(+,/1,+1+%(7*$;<(+,#(,<?W*.(,J<$+*(,)/),(@2&1+*$F(KD,S/1.,%/'7<"*(.,+(+,
$)9/.'&*$/)+5,F/1+,&F(V,<(,+$*(,$)*(.)(*,2**7OccdddD+('&$)(+-./++(++(D%/',(*,%(<1$,#1,
%()*.(,#(,."9".()%(,#(+,&-()*+,*".&*/-B)(+,www.lecrat.org/ I1$,&77/.*(.&,#(+,."7/)+(+,+1.,
<&,*".&*/-()B+(,#?1),'"#$%&'()*,&$)+$,I1(,+1.,<&,7.$+(,(),%2&.-(,#?1)(,7&*2/</-$(,
%2./)$I1(,&1,%/1.+,#(,<&,-./++(++(D,
,
!
!
!
!
Les!nausées!et!vomissements,<$"+,A,<&,-./++(++(,O,$<+,+/)*,9."I1()*+5,+1.*/1*,&1,T(.,,
*.$'(+*.(D,e&)+,<&,7<17&.*,#(+,%&+,#(,)&1+"(+RF/'$++('()*+,'/#"."+,#(,<&,-./++(++(5,<(+,
'(+1.(+,2P-$")/#$"*"*$I1(+,+199$+()*,O,&#&7*(.,<(+,7.$+(+,#(,)/1..$*1.(,Q,%2/$+$.,#(+,&<$'()*+,
&77"*$++&)*+,(*,"F$*(.,<(+,&1*.(+,Q,7.()#.(,#(+,7(*$*+,.(7&+,9."I1()*+,&1,%/1.+,#(,<&,f/1.)"(,Q,
;/$.(,(),7(*$*(,I1&)*$*",(*,+/1F()*,Q,7."9".(.,#(+,.(7&+,.$%2(+,(),+1%.(+5,<()*+,/1,.&7$#(+5,(*,
7&1F.(+,(),-.&$++(D,g1&)#,1),*.&$*('()*,'"#$%&'()*(1@,#(,<&,)&1+"(RF/'$++('()*,
'/#"."+,(+*,)"%(++&$.(,%2(V,<&,9(''(,()%($)*(,/1,+1+%(7*$;<(,#(,<?W*.(5,<(,7.('$(.,%2/$@,(+*,
<&,#/@P<&'$)(,Jea0a8!h>K5,1),*.&$*('()*,&)*$2$+*&'$)$I1(,iT5,1)(,&1*.(,/7*$/),(+*,<(,
'"*/%</7.&'$#(,I1$,/)*,'/)*.",1)(,%(.*&$)(,+"%1.$*",%2(V,<(+,9(''(+,(@7/+"(+,&1,T,(.,
*.$'(+*.(,#(,-./++(++(D,0"&)'/$)+,<&,#/'7".$#/)(,(+*,A,"F$*(.,%&.,(<<(,(@7/+(,A,#(+,(99(*+,
$)#"+$.&;<(+,%&.#$&I1(+,-.&F(+D,,
Le!paludisme!chez!la!femme!enceinte!:,1)(,'"*&,&)&<P+(,#?&.*$%<(+,71;<$"+,&F&)*,&/j*,
YUT\,+1--B.(,I1(,<?&.*(+1)&*(,7/1..&$*,W*.(,1*$<$+",#&)+,<(,*.&$*('()*,#1,7&<1#$+'(,-.&F(,#(,
<&,9(''(,()%($)*(5,I1(<I1(,+/$*,<(,+*&#(,#(,<&,-./++(++(5,'W'(,+$,<?a!3,)(,.(%/''&)#(,
<?1*$<$+&*$/),#(,<&,I1$)$)(,/1,#(,<?&.*(+1)&*(,I1?&1,T(.,*.$'(+*.(,#(,-./++(++(TD,
Femmes!enceintes!et!médicaments!utilisés!dans!les!douleurs!O,I1&)#,1),
'"#$%&'()*,(+*,f1+*$9$"5,<(,7&.&%"*&'/<,(+*,<?&)*&<-$I1(,#(,T(.,%2/$@,7/1.,<(+,#/1<(1.+,
<"-B.(+,A,'/#"."(+,(),#(2/.+,#(,<&,-./++(++(,(*,7()#&)*,<&,-./++(++(5,I1(<I1(,+/$*,<(,
*(.'(YD,>(,7&.&%"*&'/<,A,#/+(,.(%/''&)#"(,)?(+*,7&+,*".&*/-B)(,)$,9/(*/*/@$I1(D,!&$+,<(+,
+1.#/+&-(+,#(,7&.&%"*&'/<,(@7/+()*,<&,9(''(,()%($)*(,(*,<?()9&)*,A,)&$*.(,A,1)(,
2"7&*/*/@$%$*",(*,1)(,)"72./*/@$%$*"D,
E),%&+,#(,#/1<(1.+,'/#"."(+,A,+"FB.(5,<&,%/#"$)(,J7&<$(.,==K,(*,<&,'/.72$)(,J7&<$(.,===K,
7(1F()*,W*.(,1*$<$+"+,I1(<I1(,+/$*,<(,*(.'(Z5YD,,
!"#$%&'()(&*+%,,%'-(."#$&-&$#'/.-01("&#$234567$#-&'$8$"9:+;."$<"&1%&'$+%$=.-##"##">$
&-'%,,"&'$8$:%;#"$1"#$"**"'#$*-"'-'-9(?;"#$=.%@"#A$
,Antibiotiques!et!grossesseO,<(+,bêtalactamines,+/)*,&1*/.$+"(+,7()#&)*,<&,-./++(++(D,
>?1*$<$+&*$/),#(+,céphalosporines,#(,ZB'(,-")".&*$/),(+*,()F$+&-(&;<(D,>(+,aminoglycosides,
+/)*,7/1.,<&,7<17&.*,#"%/)+($<<"+,(),.&$+/),#(,<(1.,*/@$%$*",.")&<(,(*,&1#$*$F(D,>&,kanamycine,
(*,<&,streptomycine,+/)*,%/)*.(,$)#$I1"(+D,
>?1*$<$+&*$/),#(,%(.*&$)+,'&%./<$#(+,J(.P*2./'P%$)(5,f/+&'P%$)(5,'$#"%&'P%$)(5,+7$.&'P%$)(K,
(+*,()F$+&-(&;<(,7()#&)*,*/1*(,<&,-./++(++(D,>?&V$*2./'P%$)(,)?(+*,(),.(F&)%2(,1*$<$+&;<(,
I1?&7.B+,<(,T(.,*.$'(+*.(D,>&,%<&.$*2./'P%$)(5,<&,#$.$*2./'P%$)(,(*,<&,./@$*2./'P%$)(,+/)*,A,
"F$*(.,7&.,7.1#()%(D,
>?1*$<$+&*$/),#(+,+P)(.-$+*(+,(*,#(+,-<P%/7(7*$#(+,(+*,()F$+&-(&;<(,7()#&)*,*/1*(,<&,
-./++(++(D,
S&.'$,<(+,I1$)/</)(+,#(,T(.(,-")".&*$/)5,<?1*$<$+&*$/),#(,<?&%$#(,7$7"'$#$I1(,(+*,()F$+&-(&;<(,
7()#&)*,*/1*(,<&,-./++(++(D,N(<<(,#(,<&,9<1'"I1$)(,(+*,#"%/)+($<<"(D,
>(+,9<1/./I1$)/</)(+,#/$F()*,*/1*(+,W*.(,"F$*"(+,7&.,7.1#()%(D,,
>?&#'$)$+*.&*$/),#(,%P%<$)(+,(+*,%/)*.(,$)#$I1"(,A,7&.*$.,#1,YB'(,*.$'(+*.(,#(,<&,-./++(++(,
J.$+I1(,#(,%/</.&*$/),#(+,#()*+,#(,<&$*K\D,
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1!6/F&%+,3e,(*,&<,Q,L.(&*$)-,+(F(.(,'&<&.$&,$),7(.-)&)%P,O,&,.(F$(d,/9,(F$#()%(D,e.1-,3&9DYUTG,k(;,QZ_JYK,OT]GR_T!
2!S.(+%.$.(,0lZG_,:/j*,YUTZ,
3!S.(+%.$.(,0lYUZ,Q,YUUU!
L&;<(&1T,<(+,*P7(+,#(,+$*1&*$/)+G],
:D :F&)*,<(,*.&$*('()*,/1,&F&)*,<&,-./++(++(,O,#"'&.%2(,7."F()*$F(,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
m)(,9(''(,(+*,*.&$*"(,&1,</)-,%/1.+,J%&.#$/7&*2$(5,#$&;B*(5,"7$<(7+$(5,'&<&#$(+,
.21'&*$+'&<(+5,7&*2/</-$(,7+P%2$&*.$I1(K,(*,#"+$.(,1)(,-./++(++(D,N/''()*,
()F$+&-(.,<&,*2".&7(1*$I1(,'&*(.)(<<(,<&,'/$)+,)/%$F(,7/1.,<?()9&)*,n,
S/+(.,<(,7./;<B'(,#(,<?$)*(.&%*$/),7/++$;<(,#(,<&,7&*2/</-$(,(*,-./++(++(,
N2/$+$.,<(,'"#$%&'()*,<(,'$(1@,%/))1,&1,%/1.+,#(,<&,-./++(++(D,0(,7&+,+/1+,
*.&$*(.,<(+,9(''(+,()%($)*(+,
S./-.&''(.,<(+,"<"'()*+,#(,+1.F($<<&)%(,%2(V,<&,'B.(,(*,<?()9&)*,
:++1.(.,1)(,;/))(,%//.#$)&*$/),#(+,'(';.(+,#(,<?"I1$7(,7.()&)*,(),%2&.-(,<&,
'B.(,(*,<?()9&)*,
m)(,9(''(,(+*,()%($)*(D,3$,1),*.&$*('()*,(+*,)"%(++&$.(5,<&,7./-.&''(.5,+$,
7/++$;<(5,&F&)*,<(,#";1*,#(,-./++(++(,(*,+?&++1.(.,#1,;/),%/)*.X<(,*2".&7(1*$I1(,#(,
<&,'&<&#$(D,E)F$+&-(.5,+$,;(+/$)5,#(+,'(+1.(+,7."F()*$F(+,
,
oD :7.B+,<(,#";1*,#1,*.&$*('()*,O,#"'&.%2(,7./+7(%*$F(,
1)(,9(''(,()%($)*(,J(*,)(,<(,+&%2&)*,7&+5,<(,7<1+,+/1F()*K,&,7.$+,#(+,'"#$%&'()*+,,
>&,#"%$+$/),(+*,1),&%*(,'"#$%&<,
, 0(,7&+,&99/<(.,O,7(1,#(,'"#$%&'()*+,f1+*$9$()*,1)(,#"%$+$/),#?$)*(..17*$/),#(,
-./++(++(,
g1(<+,+/)*,<(+,.$+I1(+,7/1.,<?()9&)*,n,
*()$.,%/'7*(,#1,%/)*(@*(,+7"%$9$I1(,O,!"#$%&<,JP,%/'7.$+,<(+,2&;$*1#(+K5,-P)"%/R
/;+*"*.$%&<5,&)*"%"#()*+,J7(.+/))(<+5,7+P%2/</-$I1(+5,9&'$<$&1@5,-")"*$I1(+K,
%/))&C*.(,7."%$+"'()*,<(,*.&$*('()*,(*,+/),'/*$9,
&)&<P+(.,<(+,#/%1'()*+,#$+7/)$;<(+,O,72&.'&%/</-$I1(+5,(';.P/</-$I1(+,(*,
"7$#"'$/</-$I1(+,
<(,9&%*(1.,21'&$),(+*,(++()*$(<,
+$,<(,*.&$*('()*,(+*,%2./)$I1(5,()F$+&-(.,<&,-./++(++(,#&)+,*/1*(,+&,#1."(,
,
ND :7.B+,<&,)&$++&)%(,O,#"'&.%2(,."*./+7(%*$F(,
m)(,9(''(,#/))(,)&$++&)%(,A,1),()9&)*,'&<9/.'",(*c/1,&P&)*,1)(,7&*2/</-$(,
)"/)&*&<(,)/),'&<9/.'&*$F(,Q,<?&)&')B+(,/;+*"*.$%&<(,7(.'(*,#(,.(*./1F(.,1)(,
7.$+(,'"#$%&'()*(1+(D,g1(<,(+*,<(,<$(),7/++$;<(,()*.(,<?(@7/+$*$/),(*,<&,'&<9/.'&*$/),
(*c/1,<&,7&*2/</-$(,n,
E)F$+&-(.,1)(,%/)+1<*&*$/),+7"%$&<$+"(,
N/''1)$I1(.,<(,%&+,A,1),+P+*B'(,#?().(-$+*.('()*,
,
, ,
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
4!Vidal online consulté le 05 avril 2015
!
5!Françoise Bavoux, Elisabeth Elefant, Elisabeth Rey, Gérard Pons. Grossesse et médicaments. Médecine
thérapeutique. 2001;7(1):69-81.!
6!Bavoux F., Elefant E. 1989. Effets indésirables des médicaments au cours de la grossesse. Règles régissant la
prescription des médicaments dans ce cas. Rev Prat Paris 39 : 873-878!
L&;<(&1,YD,!"#$%&'()*+,*".&*/-B)(+,\5^,
Médicaments!
Malformations!plus!
fréquentes!
Conduite!à!tenir!
:D,N(+,'"#$%&'()*+,7/+()*,<(,7./;<B'(,#(,7/1.+1$*(,#(,<&,-./++(++(,O,<(+,7<1+,%/))1+,+/)*,<(,*2&<$#/'$#(5,<(,
#$"*2P<+*$<;(+*./<5,<&,.&#$/*2".&7$(5,<(+,&)*$%&)%".(1@D,
L2&<$#/'$#(,,
3I1(<(**(,J'(';.(+K,
%/(1.,
N/)*.(R$)#$%&*$/),&;+/<1(,7()#&)*,<&,
-./++(++(,
>")&<$#/'$#(,
!"#$%&'()*,
+*.1%*1.(<<('()*,7./%2(,
#1,*2&<$#/'$#(,
=+/*.(*$)/p)(,
J8a:NmL:0E5,S8aNmL:5,
Nm8:N0E5,Na0L8:N0E5,
:N0EL8:=LK,
3P+*B'(,)(.F(1@,%()*.&<5,
/.($<<(,(@*(.)(,(*,%/(1.,
N2(V,<&,9(''(,+1+%(7*$;<(,#?W*.(,()%($)*(5,
<?$)#$%&*$/),#(,%(,*.&$*('()*,#/$*,W*.(,
9(.'('()*,7(+"(D,3?$<,(+*,$)#$+7()+&;<(5,
1)(,%/)*.&%(7*$/),.$-/1.(1+('()*,+1$F$(,
#/$*,W*.(,7.(+%.$*(D,=+/*.(*$)/p)(,O,<&,
-./++(++(,(+*,A,"F$*(.,#&)+,<(,'/$+,+1$F&)*,
<?&..W*,#1,*.&$*('()*,
:%*.(*$)(,3a8=:L:0E,O,-./++(++(,A,"F$*(.,
#&)+,<(+,Y,&))"(+,+1$F&)*,<?&..W*,#1,
*.&$*('()*5,(),.&$+/),#(,<?&%%1'1<&*$/),
*$++1<&$.(,
:%$*.(*$)(,J3a8=:L:0EK,
o(&1%/17,'/$)+,#(,
#/))"(+,#$+7/)$;<(+,
I1(<I1(+,'&<9/.'&*$/)+,
#1,+I1(<(**(,
oD,>(,7./;<B'(,7/+",(+*,%(<1$,#(,<?&77."%$&*$/),#1,;")"9$%(,'&*(.)(<,&**()#1,J(*,#(+,#$99$%1<*"+,#1,
.(<&$+,*2".&7(1*$I1(K,7&.,.&77/.*,A,1),.$+I1(,9M*&<,7/1.,<(I1(<,<(+,7/++$;$<$*"+,#(,#$&-)/+*$%,
&)*")&*&<,(@$+*()*D,
>$*2$1',0Em8a>=Li=m!5,
LE8:>=LE,
N&.#$&I1(,,
3$,7/++$;<(,&..W*,f1+I1?&1,G]('(,f/1.,m)(,
(@7/+$*$/),&1,>$*2$1',#?1)(,9(''(,
"I1$<$;."(,7(1*,W*.(,-".",7&.,1)(,"I1$7(,
+7"%$&<$+"(,
N(.*&$),&)*$,"7$<(7*$I1(+,
:)/'&<$(,#(,9(.'(*1.(,
#1,*1;(,)(1.&<,J:kL0K,
:,)?1*$<$+(.,I1?(),<?&;+()%(,#?&<*(.)&*$F(,
%2(V,<&,9(''(,()%($)*(,(*,<&,9(''(,(),q-(,
#(,7./%."(.,+&)+,%/)*.&%(7*$/)D,
3&)+,7.(1F(,#?(99$%&%$*",7./7/+$*$/),#(,
7."F()*$/),#(,+1.F()1(,#?:kL0,7&.,<?&%$#(,
9/<$I1(,Y,'/$+,&F&)*,(*,T,'/$+,&7.B+,<&,
%/)%(7*$/),+&)+,#"7&++(.,G,'-cY\2,
r&<7./&*(,#(,+/#$1',
eES:6=0E,
N&.;&'&V(7$)(,
LE[8ELa>,
S2")P*/p)(,,
N.q)$/9&%$&<(,(*,72&<&)-(,
E%2/-.&72$(,&@"(,+1.,<(+,/.-&)(+,%$;<(+,
:)*$%/&-1<&)*+,/.&1@,
J:r6K,
eP+'/.72$(,9&%$&<(5,
2P7/7<&+$(,#(+,72&<&)-(+,
#(+,'&$)+,(*,#(+,7$(#+,
&)/'&<$(,%".";.&<(,7/1.,
<(+,(@7/+$*$/)+,&1,%/1.+,
#(+,Y('(,(*,Z,('(,
*.$'(+*.(+,
8(<&$+,7&.,2"7&.$)(,#B+,<(,#$&-)/+*$%,#(,<&,
-./++(++(,,
:)*$%&)%".(1@,O,>?$)#$%&*$/),#(+,&)*$%&)%".(1@,(*c/1,#(,<&,.&#$/*2".&7$(,7/+(,<(,7./;<B'(,#(,
<?"F&<1&*$/),#1,.&77/.*,;")"9$%(c.$+I1(,I1$,)(,7(1*,W*.(,"*1#$",I1?&1,%&+,7&.,%&+D,
,
, ,
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
7!Françoise Bavoux, Elisabeth Elefant, Elisabeth Rey, Gérard Pons. Grossesse et médicaments. Médecine
thérapeutique. 2001;7(1):69-81.!
Tableau!3!O,&1*.(+,'"#$%&'()*+,A,.$+I1(,9M*&<,(*c,/1,)"/)&*&<,J<$+*(,)/),(@2&1+*$F(K\,
!"#$%&'()*+,
!&)$9(+*&*$/)+,<(+,7<1+,
9."I1()*(+,
N/)#1$*(,A,*()$.,
:=03,JP,%/'7.$+,<(+,&)*$,N/@YK,
L/@$%$*",.")&<(,#B+,TY,+('&$)(+,
k(.'(*1.(,#1,%&)&<,&.*".$(<<(,
J'/.*,$),1*(./K,
N/)*.(,$)#$%&*$/),A,7&.*$.,#1,
Y\B'(,+('&$)(,#?&'")/..2"(,JP,
%/'7.$+,<&,F/$(,+/1+,%1*&)"(,
=)2$;$*(1.+,#(,<?()VP'(,#(,
%/)F(.+$/),J=ENK,
3&.*&)+,J:8:==K,
&<$+4$.()(,
L/@$%$*",.")&<(,#B+,TY,+('&$)(+,,
N/)*.(R$)#$%&*$/),#B+,<(,ZB'(,
'/$+,O,+1;+*$*1*$/),<(,7<1+,*X*,
7/++$;<(,7&.,1)(,&1*.(,%<&++(,
#?&)*$2P7(.*()+(1.,
r&<7./&*(,#(,+/#$1',
L2./';/7")$(5,#$'$)1*$/),#(,
<?&-."-&*$/),7<&I1(**&$.(,
e$'$)1*$/),#(+,%&7&%$*"+,
F(.;&<(+,A,<?q-(,+%/<&$.(,
E@7</.&*$/),#(,<?2"'/+*&+(,
%2(V,<&,'B.(,,
0/1F(&1R)",O,+1.F($<<&)%(,#(+,
7<&I1(**(+5,-<P%"'$(,
0(1./<(7*$I1(,,
3$-)(+,&*./7$)$I1(+,
!B.(,O,9&F/.$+(.,<&,
'/)/*2".&7$(,&F(%,#$'$)1*$/),
#(+,#/+(+,7()#&)*,<(+,Y,
#(.)$(.+,'/$+,
0/1F(&1R)",+1.F($<<&)%(,
)(1./</-$I1(,(*,#$-(+*$F(,,
:)*$#"7.(++(1.,$'$7.&'$)$I1(+,
3$-)(+,&*./7$)$I1(+,
0/1F(&1R)",+1.F($<<&)%(,
)(1./</-$I1(,(*,#$-(+*$F(,
=)2$;$*(1.,#(,<&,.(%&7*1.(,#(,<&,
+"./*/)$)(,s=83t,
iP7/*2(.'$(5,&-$*&*$/)5,7<(1.+,
(@%(++$9+5,*.(';<('()*+,
$..$*&;$<$*"5,$)+/')$(D,
8$+I1(,&%%.1,#?iL:S,
0/1F(&1R)",+1.F($<<&)%(,#1,
%/'7/.*('()*,,
o()V/#$&V"7$)(+,
L./1;<(,#(,<&,+1%%$/)5,
+/')/<()%(5,2P7/*/)$(5,
#"7.(++$/),.(+7$.&*/$.(5,&7)"(,,
!B.(,7."9".(.,+$,7/++$;<(,
<?/@&V"7&'5,A,#('$,F$(,
$)*(.'"#$&$.(,,
0/1F(&1R)",+1.F($<<&)%(,#1,
%/'7/.*('()*,(*,#(,<&,
.(+7$.&*$/),
oW*&;</I1&)*+,
iP7/-<P%"'$(,
o.&#P%&.#$(,
=)+199$+&)%(,%&.#$&I1(,
iP7/*()+$/),
0/1F(&1R)",+1.F($<<&)%(,#(,<&,
-<P%"'$(5,7.(++$/),&.*".$(<<(,(*,
9."I1()%(,%&.#$&I1(,
,
1 / 5 100%
La catégorie de ce document est-elle correcte?
Merci pour votre participation!

Faire une suggestion

Avez-vous trouvé des erreurs dans linterface ou les textes ? Ou savez-vous comment améliorer linterface utilisateur de StudyLib ? Nhésitez pas à envoyer vos suggestions. Cest très important pour nous !